InvestorsHub Logo
icon url

bas2020

01/23/17 4:00 PM

#88532 RE: kld2 #88531

Most institutions have guidelines of not investing in a startup biotech until its drug is, at least, into Phase 3.

Partnership prospects are completely different.

icon url

Rubyred77

01/23/17 4:06 PM

#88534 RE: kld2 #88531

Tutes are starting to show interest. Russell Investments Group just filed their 13F which shows they have 25486 shares worth $102K. Im sure more will follow towards the end of the quarter.
icon url

XenaLives

01/23/17 5:13 PM

#88544 RE: kld2 #88531

But it keeps going up..


Tute participation is quite paltry.



Early stage biotech that's been on the NASDAQ a little over a year.